Back to top

Analyst Blog

Shares of AmerisourceBergen Corp. (ABC - Analyst Report) dipped 3.6% yesterday, following the decision of the company's Executive Vice President and Chief Financial Officer (CFO) Michael D. DiCandilo to vacate his office immediately. Mr. DiCandilo, who resigned to pursue other interests, was with AmerisourceBergen for 21 years, including his 10 year tenure of serving as the CFO of the company.

The company stated that Tim G. Guttman, the company's Vice President and Corporate Controller since 2002, will immediately take over as the acting CFO. Mr. Guttman was earlier the Vice President, Finance of Syncor International, and has held financial planning and financial services managerial positions at Disney Consumer Products, Pizza Hut, Inc. and Pepsico Inc. (PEP - Analyst Report).

2012 Guidance Backed

Following the news, AmerisourceBergen reaffirmed its guidance for fiscal 2012 (ending September 30). It continues to expect earnings in the range of $2.74 to $2.84 per share. The Zacks Consensus Estimate of $2.81 is pegged at the higher end of the guidance range.

The company maintains the flat-to-modest revenue growth projection, and intends to spend about $400 million on share repurchases in fiscal 2012.

Further, AmerisourceBergen expects operating margin to grow in the high single-digit to low double-digit basis points range. Free cash flow, which includes capital expenditures of about $150 million, is expected in the range of $700 to $800 million.

Neutral on AmerisourceBergen

We currently have a Neutral recommendation on AmerisourceBergen. The stock carries a Zacks #3 Rank (Hold rating) in the short-run. We believe the company is well-positioned for growth given the strong performance of its generics business. AmerisourceBergen boasts of a robust plasma and vaccine business, which are expected to contribute strong revenues in the coming quarters.

However, AmerisourceBergen operates in a highly competitive pharmaceutical distribution market, with players like Cardinal Health Inc. (CAH - Analyst Report) and McKesson Corp. (MCK - Analyst Report).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
ERBA DIAGNO… ERB 3.00 +3.09%
SANCHEZ ENE… SN 34.18 +2.67%
THE PANTRY… PTRY 21.02 +2.09%
INTEL CP INTC 35.15 +1.88%
CLAYTON WIL… CWEI 117.30 +1.78%